Home » Topics » Regulatory » Patents

Patents
RSS

Continuing focus on PARP inhibitors at Guilford

April 29, 1999

Guilford's new PARP inhibitors potentially useful for wide variety of disorders

April 28, 1999

Tryptamine analogues as potent and selective human 5-HT2A antagonists

April 28, 1999

U.S. patent issued to NitroMed, providing protection for MED/FSAD treatment program

April 28, 1999

Inhibitors of NOS described by Pfizer

April 28, 1999

Kissei designs new series with potent and selective bronchodilating effects

April 28, 1999

Dual-action antiatherosclerotic agents in the Sankyo pipeline

April 27, 1999

New cyclic compounds designed at JT reduce only elevated blood glucose levels

April 27, 1999

Urethra-selective alpha1-agonists under development at Mitsui for urinary incontinence

April 27, 1999

Series from Takeda with neuroprotective effects

April 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...